Handel Eyenovia, Inc. - EYEN CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | - | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
| Gebyr natten over, tid | 21:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Nøglestatistikker
| Tidligere luk* | N/A |
| Åben* | N/A |
| 1-Års Ændring* | N/A |
| Dagens Spænd* | N/A |
| 52-Ugers Spænd | 1.50-3.34 |
| Gennemsnitlig Volumen (10 dage) | 101.90K |
| Gennemsnitlig Volumen (3 måneder) | 4.14M |
| Market Cap | 102.95M |
| P/E-forhold | -100.00K |
| Udestående aktier | 36.12M |
| Omsætning | 10.00M |
| EPS | -0.56 |
| Dividend (Udbytte %) | N/A |
| Beta | 1.67 |
| Næste indtjeningsopgørelse | Mar 27, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|
Eyenovia, Inc. Events
| Tid (UTC) (UTC) | Land | Begivenhed |
|---|---|---|
| No events scheduled | ||
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Total omsætning | 14 | 2 | 0 | 0 | 0 |
| Omsætning | 14 | 2 | 0 | ||
| Totale Driftsudgifter | 26.4403 | 21.7892 | 21.3085 | 17.2564 | 5.13237 |
| Salgs/Generelle/Admin. Udgifter, Total | 10.7842 | 7.69759 | 7.20051 | 6.13618 | 1.31564 |
| Forskning & Udvikling | 14.2979 | 13.1962 | 14.0927 | 11.1011 | 3.79127 |
| Depreciation / Amortization | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
| Driftsindtægter | -12.4403 | -19.7892 | -21.3085 | -17.2564 | -5.13237 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -0.38524 | 0.00936 | 0.15179 | 0.00334 | 0.00238 |
| Netto Indkomst Før Skat | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Netto Indkomst Efter Skat | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Netto Indkomst Før Ekstra Ting | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Netto Indkomst | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Fortyndelsesændring | |||||
| Fortyndet Netto Indkomst | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Fortyndet Vægtet Gennemsnit Aktier | 26.3241 | 21.0547 | 14.3497 | 9.47671 | 9.93677 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.48543 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Fortyndet Normaliseret EPS | -0.50303 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
| Totale Ekstraordinære Ting | 0 | ||||
| Kost af omsætning, Total | 1.6 | 0.8 | |||
| Bruttofortjeneste | 12.4 | 1.2 | |||
| Andre, Netto | 0.04718 | 0.01 | |||
| Usædvanlig Udgift (Indkomst) | -0.46335 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 10 | 0 | 2 | 2 |
| Omsætning | 0 | 10 | 0 | 2 | 2 |
| Kost af omsætning, Total | 0 | 0 | 0 | 0.8 | 0.8 |
| Bruttofortjeneste | 0 | 10 | 0 | 1.2 | 1.2 |
| Totale Driftsudgifter | 7.18755 | 6.88673 | 5.44198 | 6.76357 | 7.36664 |
| Salgs/Generelle/Admin. Udgifter, Total | 3.47497 | 3.7115 | 2.43514 | 2.34719 | 2.24399 |
| Forskning & Udvikling | 3.71258 | 3.17523 | 3.47019 | 3.61638 | 4.32265 |
| Driftsindtægter | -7.18755 | 3.11327 | -5.44198 | -4.76357 | -5.36664 |
| Renteindkomst (Udgift), Netto Ikke-Drift | -0.14505 | -0.18519 | -0.11861 | -0.07783 | -0.00362 |
| Andre, Netto | -0.00707 | 0.05519 | -0.00801 | 0 | 0.01859 |
| Netto Indkomst Før Skat | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Netto Indkomst Efter Skat | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Netto Indkomst Før Ekstra Ting | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Netto Indkomst | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Fortyndet Netto Indkomst | -7.33967 | 2.98328 | -5.5686 | -4.8414 | -5.35167 |
| Fortyndet Vægtet Gennemsnit Aktier | 30.0082 | 27.977 | 26.0535 | 25.9273 | 25.3306 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.24459 | 0.10663 | -0.21374 | -0.18673 | -0.21127 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Fortyndet Normaliseret EPS | -0.24459 | 0.10663 | -0.23152 | -0.18673 | -0.21127 |
| Usædvanlig Udgift (Indkomst) | 0 | -0.46335 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 29.8769 | 33.3913 | 14.3493 | 19.861 | 5.28666 |
| Likvider og Kortsigtede Investeringer | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
| Cash | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
| Prepaid Expenses | 0.38663 | 0.2898 | 0.07737 | 0.13276 | 0.03715 |
| Total Assets | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
| Property/Plant/Equipment, Total - Net | 1.27123 | 0.39638 | 0.23054 | 0.03674 | 0.02796 |
| Property/Plant/Equipment, Total - Gross | 1.59963 | 0.57329 | 0.31203 | 0.10289 | 0.07498 |
| Accumulated Depreciation, Total | -0.32841 | -0.17691 | -0.08149 | -0.06615 | -0.04702 |
| Total Current Liabilities | 11.1725 | 18.1984 | 2.91166 | 3.09884 | 0.55265 |
| Accounts Payable | 1.6141 | 1.46167 | 1.54136 | 1.50952 | 0.24638 |
| Accrued Expenses | 2.32693 | 2.57974 | 1.31332 | 1.56769 | 0.29529 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 0.08109 | 14.0594 | 0.05698 | 0.02163 | 0.01098 |
| Total Liabilities | 11.1924 | 18.6029 | 2.95701 | 3.14043 | 0.55265 |
| Total Long Term Debt | 0 | 0.36581 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.01995 | 0.03868 | 0.04535 | 0.04158 | 0 |
| Total Equity | 20.4666 | 15.3039 | 11.7406 | 16.8751 | 5.09067 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Preferred Stock - Non Redeemable, Net | 0.00046 | ||||
| Common Stock | 0.00284 | 0.0025 | 0.00171 | 0.00115 | 0.00026 |
| Additional Paid-In Capital | 110.683 | 92.7423 | 69.41 | 53.3882 | 24.3511 |
| Retained Earnings (Accumulated Deficit) | -90.2193 | -77.4409 | -57.6711 | -36.5143 | -19.2612 |
| Total Liabilities & Shareholders’ Equity | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
| Total Common Shares Outstanding | 28.4266 | 24.9786 | 17.1007 | 11.469 | 9.93677 |
| Other Long Term Assets, Total | 0.51098 | 0.11904 | 0.1178 | 0.1178 | 0.3287 |
| Totale Tilgodehavender, Netto | 2.14885 | 3.11798 | 0.09523 | ||
| Other Current Assets, Total | 7.87953 | 1.61173 | 0.02408 | ||
| Current Port. of LT Debt/Capital Leases | 7.15037 | 0.09754 | |||
| Long Term Debt | 0 | 0.36581 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 30.3986 | 29.8769 | 23.4593 | 29.495 | 28.0252 |
| Likvider og Kortsigtede Investeringer | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
| Cash | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
| Totale Tilgodehavender, Netto | 1.85222 | 2.14885 | 1.25767 | 1.17134 | 1.17891 |
| Prepaid Expenses | 1.79656 | 0.38663 | 0.77768 | 1.04895 | 1.089 |
| Other Current Assets, Total | 0.03358 | 7.87953 | 7.92312 | 0.09787 | 0.85025 |
| Total Assets | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
| Property/Plant/Equipment, Total - Net | 1.37036 | 1.27123 | 1.4132 | 0.96888 | 0.70742 |
| Other Long Term Assets, Total | 8.41907 | 0.51098 | 0.11904 | 0.11904 | 0.11904 |
| Total Current Liabilities | 10.3788 | 11.1725 | 20.7194 | 14.5598 | 16.3656 |
| Accounts Payable | 1.53476 | 1.6141 | 1.68473 | 1.66763 | 1.81512 |
| Accrued Expenses | 1.05726 | 2.32693 | 1.68645 | 1.86687 | 1.7253 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 7.74012 | 7.15037 | 7.28204 | 0.95976 | 0.78382 |
| Other Current Liabilities, Total | 0.04662 | 0.08109 | 10.0662 | 10.0656 | 12.0414 |
| Total Liabilities | 10.3939 | 11.1924 | 20.7454 | 21.5924 | 16.7115 |
| Total Long Term Debt | 0 | 0 | 0 | 6.99489 | 0.30729 |
| Long Term Debt | 0 | 0 | 6.99489 | 0.30729 | |
| Other Liabilities, Total | 0.01508 | 0.01995 | 0.02606 | 0.03763 | 0.03863 |
| Total Equity | 29.7942 | 20.4666 | 4.24614 | 8.99056 | 12.1401 |
| Redeemable Preferred Stock | 0 | 0 | 0 | ||
| Common Stock | 0.00317 | 0.00284 | 0.0026 | 0.0026 | 0.00256 |
| Additional Paid-In Capital | 127.35 | 110.683 | 97.4461 | 96.6219 | 94.9301 |
| Retained Earnings (Accumulated Deficit) | -97.559 | -90.2193 | -93.2026 | -87.634 | -82.7926 |
| Total Liabilities & Shareholders’ Equity | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
| Total Common Shares Outstanding | 31.6984 | 28.4266 | 25.9632 | 25.9466 | 25.6236 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netto indkomst/Startlinje | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
| Likvider Fra Driftsaktiviteter | -20.8744 | -6.38428 | -18.9193 | -13.1111 | -4.73111 |
| Likvider Fra Driftsaktiviteter | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
| Ikke-Likvide Ting | 2.43593 | 2.48317 | 2.51194 | 1.61547 | 0.41231 |
| Cash Taxes Paid | |||||
| Likvid Rente Betalt | 0.22717 | 0.01397 | |||
| Ændringer i Driftskapital | -10.7535 | 10.807 | -0.28984 | 2.50737 | -0.0389 |
| Likvider fra Investeringsaktiviteter | -1.61852 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
| Kapitaludgifter | -1.22658 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
| Andre Investerings-Cash-Flow-Ting, Total | -0.39194 | ||||
| Likvider fra Financieringsaktiviteter | 21.458 | 20.8648 | 13.5104 | 27.6177 | 6.60357 |
| Udstedelse (Pensionering) af Aktier, Netto | 14.7299 | 20.8766 | 13.5104 | 27.6177 | 6.60357 |
| Netto Ændring i Likviditet | -1.03498 | 14.2192 | -5.5756 | 14.4787 | 1.86222 |
| Udstedelse (Pensionering) af Gæld, Netto | 6.72802 | -0.01186 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.33967 | -12.7784 | -15.7617 | -10.1931 | -5.35167 |
| Cash From Operating Activities | -8.1844 | -20.8744 | -14.9978 | -9.90314 | -4.57385 |
| Cash From Operating Activities | 0.07543 | 0.22156 | 0.14825 | 0.07524 | 0.03328 |
| Non-Cash Items | 0.9352 | 2.43593 | 1.65033 | 1.30978 | 0.65691 |
| Cash Interest Paid | 0.09559 | 0.22717 | 0.13184 | 0.07046 | 0.004 |
| Changes in Working Capital | -1.85537 | -10.7535 | -1.03471 | -1.0951 | 0.08763 |
| Cash From Investing Activities | -0.20766 | -1.61852 | -1.16507 | -0.64774 | -0.34432 |
| Capital Expenditures | -0.17457 | -1.22658 | -1.16507 | -0.64774 | -0.34432 |
| Cash From Financing Activities | 15.6465 | 21.458 | 9.16692 | 9.3559 | 1.45339 |
| Financing Cash Flow Items | -0.08339 | 0 | |||
| Issuance (Retirement) of Stock, Net | 15.8417 | 14.7299 | 2.28079 | 2.23408 | 1.53099 |
| Issuance (Retirement) of Debt, Net | -0.11179 | 6.72802 | 6.88612 | 7.12182 | -0.0776 |
| Net Change in Cash | 7.25442 | -1.03498 | -6.99596 | -1.19499 | -3.46478 |
| Cash Taxes Paid | 0 | 0 | |||
| Other Investing Cash Flow Items, Total | -0.0331 | -0.39194 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| Grant (Stuart M) | Individual Investor | 14.2096 | 5132677 | 21753 | 2022-12-30 | LOW |
| Eshelman (Fredric N) | Individual Investor | 4.4624 | 1611872 | -6963 | 2022-11-10 | LOW |
| Ianchulev (Tsontcho M.D.) | Individual Investor | 3.3016 | 1192562 | -21316 | 2022-12-27 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5451 | 919322 | -8433 | 2022-12-31 | LOW |
| Medical Strategy GmbH | Investment Advisor | 1.922 | 694259 | 0 | 2022-09-30 | LOW |
| Avenue Capital Group | Investment Advisor/Hedge Fund | 1.5166 | 547807 | 547807 | 2022-12-31 | HIGH |
| Mario (Ernest B) | Individual Investor | 1.0595 | 382706 | 6963 | 2021-11-17 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9314 | 336432 | 336432 | 2022-12-31 | LOW |
| Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8721 | 315029 | 315029 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.7987 | 288500 | 24400 | 2022-12-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.72 | 260067 | 6056 | 2022-12-31 | LOW |
| Millennium Management LLC | Hedge Fund | 0.2507 | 90568 | 14153 | 2022-12-31 | HIGH |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2035 | 73517 | 11900 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1954 | 70581 | 1159 | 2022-12-31 | LOW |
| Mather (Charles E IV) | Individual Investor | 0.1953 | 70544 | 22222 | 2022-06-16 | LOW |
| Clasby (Jennifer G) | Individual Investor | 0.1842 | 66537 | 10835 | 2021-06-17 | |
| Lee (Kenneth B Jr) | Individual Investor | 0.1787 | 64544 | 22222 | 2022-06-16 | LOW |
| Bridgeway Capital Management, LLC | Investment Advisor | 0.1326 | 47900 | 0 | 2022-12-31 | LOW |
| Oak Family Advisors, LLC | Investment Advisor/Hedge Fund | 0.1276 | 46073 | -13113 | 2022-12-31 | MED |
| BNY Mellon Asset Management | Investment Advisor | 0.1228 | 44374 | -1136 | 2022-12-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
Handelskurtage
0
- 1:1
Gearing
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Eyenovia, Inc. Company profile
Om Eyenovia, Inc.
Eyenovia, Inc. er en klinisk virksomhed inden for oftalmologi. Virksomheden er ved at udvikle en pipeline af terapeutika baseret på en MAP-platformteknologi (microdose array print). Virksomhedens pipeline er fokuseret på udvikling i den sene fase af mikrodoseret medicin mod progressiv nærsynethed, presbyopi og mydriasis. Selskabets produktkandidater omfatter MydCombi, MicroPine og MicroLine. MydCombi er et produkt med en kombination af mikroformulering (phenylephrin-tropicamid) til farmakologisk mydriasis (øjendilatation). MicroPine er en aktuel behandling til behandling af progressiv myopi, en øjensygdom, der er forbundet med patologisk aksial forlængelse og sclero-retinal udstrækning. MicroLine er en kandidat, som udvikler en mikrodoseret version af pilocarpin, en øjenmedicin, der dosisafhængigt kan fremkalde miosis, dvs. en sammentrækning af pupillen.
| Industry: | Pharmaceuticals (NEC) |
295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com